These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23396728)

  • 1. S-adenosylmethionine metabolism and liver disease.
    Mato JM; Martínez-Chantar ML; Lu SC
    Ann Hepatol; 2013; 12(2):183-9. PubMed ID: 23396728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet.
    Wortham M; He L; Gyamfi M; Copple BL; Wan YJ
    Dig Dis Sci; 2008 Oct; 53(10):2761-74. PubMed ID: 18299981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-adenosylmethionine in liver health, injury, and cancer.
    Lu SC; Mato JM
    Physiol Rev; 2012 Oct; 92(4):1515-42. PubMed ID: 23073625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver.
    Lu SC; Huang ZZ; Yang H; Mato JM; Avila MA; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2000 Jul; 279(1):G178-85. PubMed ID: 10898761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of S-adenosylmethionine Metabolism in Nonalcoholic Steatohepatitis Leads to Polyamine Flux and Oxidative Stress.
    Quinn C; Rico MC; Merali C; Merali S
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of S-adenosyl-L-methionine in the treatment of liver diseases.
    Lieber CS
    J Hepatol; 1999 Jun; 30(6):1155-9. PubMed ID: 10406198
    [No Abstract]   [Full Text] [Related]  

  • 7. Methionine adenosyltransferases in liver cancer.
    Murray B; Barbier-Torres L; Fan W; Mato JM; Lu SC
    World J Gastroenterol; 2019 Aug; 25(31):4300-4319. PubMed ID: 31496615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma.
    Pascale RM; Peitta G; Simile MM; Feo F
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31234428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.
    Cano A; Buqué X; Martínez-Uña M; Aurrekoetxea I; Menor A; García-Rodríguez JL; Lu SC; Martínez-Chantar ML; Mato JM; Ochoa B; Aspichueta P
    Hepatology; 2011 Dec; 54(6):1975-86. PubMed ID: 21837751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer.
    Lu SC; Mato JM
    Alcohol; 2005 Apr; 35(3):227-34. PubMed ID: 16054984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished S-adenosylmethionine biosynthesis and its metabolism in a model of hepatocellular carcinoma is recuperated by an adenosine derivative.
    Lozano-Rosas MG; Chávez E; Velasco-Loyden G; Domínguez-López M; Martínez-Pérez L; Chagoya De Sánchez V
    Cancer Biol Ther; 2020; 21(1):81-94. PubMed ID: 31552788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
    Martínez-Uña M; Varela-Rey M; Mestre D; Fernández-Ares L; Fresnedo O; Fernandez-Ramos D; Gutiérrez-de Juan V; Martin-Guerrero I; García-Orad A; Luka Z; Wagner C; Lu SC; García-Monzón C; Finnell RH; Aurrekoetxea I; Buqué X; Martínez-Chantar ML; Mato JM; Aspichueta P
    J Hepatol; 2015 Mar; 62(3):673-81. PubMed ID: 25457203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent.
    Pascale RM; Simile MM; Calvisi DF; Feo CF; Feo F
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of methionine in liver disease.
    Mato JM; Ortiz P
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():35-46. PubMed ID: 8899692
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Chow MD; Lee YH; Guo GL
    Mol Aspects Med; 2017 Aug; 56():34-44. PubMed ID: 28442273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron in NASH, chronic liver diseases and HCC: how much iron is too much?
    Pietrangelo A
    J Hepatol; 2009 Feb; 50(2):249-51. PubMed ID: 19070915
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis.
    Martínez-López N; Varela-Rey M; Fernández-Ramos D; Woodhoo A; Vázquez-Chantada M; Embade N; Espinosa-Hevia L; Bustamante FJ; Parada LA; Rodriguez MS; Lu SC; Mato JM; Martínez-Chantar ML
    Hepatology; 2010 Nov; 52(5):1621-31. PubMed ID: 20815019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications.
    Mato JM; Alvarez L; Ortiz P; Pajares MA
    Pharmacol Ther; 1997; 73(3):265-80. PubMed ID: 9175157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of hepatocellular carcinoma in mice with a chronic deficiency of hepatic s-adenosylmethionine: relevance in human liver diseases.
    Santamaría E; Muñoz J; Fernandez-Irigoyen J; Sesma L; Mora MI; Berasain C; Lu SC; Mato JM; Prieto J; Avila MA; Corrales FJ
    J Proteome Res; 2006 Apr; 5(4):944-53. PubMed ID: 16602702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.